Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) with a price target ...

U.S. stock indexes rose on Tuesday, driven by gains in chipmakers like Nvidia, amid anticipation of trade talks between U.S.

CoreWeave's emerged as a strong contender for market's AI darling, as evidenced in the stock's steep upsurge since its March ...